XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Acquisition (Table)
3 Months Ended
Sep. 30, 2023
Schedule Of recognized identified assets acquired, and liabilities assumed

Cash

 

$1,500,000

 

Convertible note payable, convertible at $6.00 per common share

 

 

1,050,000

 

Earnout payment

 

 

-

 

Common stock, 555,489 shares valued at $5.34 per common share, the closing price on April 1, 2022.

 

 

2,965,756

 

 

 

$5,515,756

 

 

 

 

 

 

Recognized amounts of identifiable assets acquired and liabilities assumed:

 

 

 

 

 

 

 

 

 

Cash

 

$471,237

 

Accounts receivable

 

 

860,882

 

Inventory

 

 

2,337,208

 

Prepaid expenses

 

 

6,900

 

Property and equipment

 

 

7,602

 

Right to use asset

 

 

410,365

 

Other asset

 

 

6,545

 

Online sales channels

 

 

1,800,000

 

Vendor relationships

 

 

6,000,000

 

Accrued liabilities

 

 

(701,606 )

Notes payable

 

 

(7,298,353 )

Operating lease

 

 

(422,479 )

Total identifiable net assets

 

$3,478,301

 

Goodwill

 

$2,037,455

 

Schedule of revenue from acquisitions

 

 

Three months ended September 30,

 

 

 

2023

 

 

2022

 

Cygnet

 

 

4,669,367

 

 

 

7,247,519

 

LuckyTail

 

 

802,504

 

 

 

824,775

 

E-Core

 

 

17,092,372

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

$22,564,243

 

 

$8,072,294

 

Schedule of pro forma

Pro Forma, Unaudited

 

 

 

 

 

 

 

 Proforma

 

 

 

Three months ended September 30, 2022

 

Upexi, Inc.

 

 

LuckyTail

 

 

E-Core

 

 

Adjustments

 

 

Proforma

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$11,218,799

 

 

$892,270

 

 

$9,420,927

 

 

$-

 

 

$21,531,996

 

Cost of sales

 

$5,501,316

 

 

$137,088

 

 

$8,208,282

 

 

$-

 

 

$13,746,686

 

Operating expenses

 

$8,194,881

 

 

$383,476

 

 

$635,608

 

 

$834,219

 

 

$10,048,184

 

Net income (loss) from continuing operations

 

$(2,745,520)

 

$-

 

 

$578,037

 

 

$(834,219)

 

$(2,629,996)

Basic income (loss) per common share

 

$(0.16)

 

$-

 

 

$0.46

 

 

$

 

 

 

$(0.15)

Weighted average shares outstanding

 

 

16,713,345

 

 

 

 

 

 

 

1,247,403

 

 

 

 

 

 

 

17,960,748

 

VitaMedica Corporation [Member]  
Schedule Of recognized identified assets acquired, and liabilities assumed

Cash

 

$2,000,000

 

Cash payment, 90 days after close

 

 

484,729

 

Cash payment, 180 days after close

 

 

469,924

 

Contingent consideration

 

 

112,685

 

Cash payment, working capital adjustment

 

 

460,901

 

 

 

$3,528,239

 

Inventory

 

$460,901

 

Trade name

 

 

383,792

 

Customer list

 

 

1,834,692

 

Total identifiable net assets

 

$2,679,385

 

Goodwill

 

$848,854

 

Fair value of consideration transferred:

 

 

 

 

 

 

 

Cash

 

$100,000

 

Cash payment, 120 days

 

 

3,000,000

 

Note payable

 

 

5,189,718

 

Note payable 2

 

 

4,684,029

 

Convertible note payable, convertible at $4.81 per common share

 

 

2,418,860

 

Common stock, 1,247,402 shares valued at $4.81 per common share, the calculated closing price on October 21, 2022.

 

 

6,000,000

 

 

 

$21,039,765

 

Cash

$1,014,610

Accounts receivable

6,699,945

Inventory

7,750,011

Prepaid expenses

75,721

Trade name

1,727,249

Customer relationships

5,080,305

Accrued liabilities

(192,051 )

Line of credit

(7,201,079 )

Total identifiable net assets

$14,635,673

Goodwill

$6,404,092